Subscribe To
Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc
The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate...
November 4, 2023, 12:00 pm
Lyra therapeutics' nasal matrix in focus: sniffing out opportunity
Lyra Therapeutics' LYR-220 shows promise in addressing chronic rhinosinusitis, targeting a patient demographic that doesn't respond to current treatme...
October 9, 2023, 1:20 am
Candel therapeutics announces three abstracts accepted for poster presentations at sitc 2023 annual meeting
One clinical poster detailing initial overall survival and immunological biomarker data from the ongoing, randomized, open-label phase 2 clinical tria...
September 27, 2023, 1:40 pm
Ascendis pharma presents results from long-term enlighten trial of transcon™ hgh in pediatric growth hormone deficiency
– The majority of children and adolescents treated once weekly with TransCon hGH (lonapegsomatropin) met or exceeded average parental height SDS at ...
September 23, 2023, 11:00 am
Berch capital led non-partisan app govside launches out of stealth to empower democracy and drive voter enlightenment
AUSTIN, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) — GovSide, the non-partisan app designed to empower democracy, is thrilled to announce it’s launch ...
September 13, 2023, 4:57 pm
Here are some of the most advanced car tech features you should know about
Every generation and era can point to technological advances, no doubt believing theirs was the time of greatest enlightenment. Today, technological a...
May 8, 2023, 5:01 am
Tricky issue of client suitability for esg investments
By George Prior As global investors become increasingly focused on environmental, social, and governance (ESG) investments, one of the world’s large...
March 3, 2023, 4:44 pm
Gold coast keto maggie beer australia [fake exposed] maggie beer weight loss scam price or is chrissie swan keto legitimate news?
In general keto, gummies are very low in sugar, carbs, and calories. They can limit the number of calories and carbs you consume and help you adhere t...
February 4, 2023, 1:14 pm
Key uk data this week; could the rally in equities be supported?
With the Bank of England meeting scheduled in less than three weeks, pound followers will be enlightened on the underlying currents of the UK economy....
January 16, 2023, 11:04 am
Nice's prospects benefit from strong portfolio growth
NICE has been awarded the Customer Experience Innovation award by TMC, a global, integrated media company, and CUSTOMER Magazine for its ...
December 28, 2022, 12:21 pm
Brazil etfs, poucos entendem isso
By Michael Venuto At the ETF Think Tank, we often say “don't think alone” (a pun from our Happy Hour). When it comes to making sense of markets, ...
February 9, 2022, 3:17 pm
Brazil etfs, poucos entendem isso
By Michael Venuto At the ETF Think Tank, we often say “don't think alone” (a pun from our Happy Hour). When it comes to making sense of markets, ...
February 9, 2022, 3:17 pm
Brazil etfs, poucos entendem isso
By Michael Venuto At the ETF Think Tank, we often say “don't think alone” (a pun from our Happy Hour). When it comes to making sense of markets, ...
February 9, 2022, 3:17 pm
Alkermes schizophrenia med shows lower mean weight gain in early illness with schizophrenia
Alkermes plc's ALKS ENLIGHTEN-Early Phase 3b study of Lybalvi (olanzapine & samidorphan) met its prespecified primary endpoint on body weight in yo...
February 8, 2022, 12:21 pm
Alkermes schizophrenia med shows lower mean weight gain in early illness with schizophrenia
Alkermes plc's ALKS ENLIGHTEN-Early Phase 3b study of Lybalvi (olanzapine & samidorphan) met its prespecified primary endpoint on body weight in yo...
February 8, 2022, 12:21 pm
Alkermes schizophrenia med shows lower mean weight gain in early illness with schizophrenia
Alkermes plc's ALKS ENLIGHTEN-Early Phase 3b study of Lybalvi (olanzapine & samidorphan) met its prespecified primary endpoint on body weight in yo...
February 8, 2022, 12:21 pm
Lyra therapeutics kickstarts lyr-210 pivotal program in surgically naïve chronic rhinosinusitis patients
Lyra Therapeutics Inc (NASDAQ: LYRA) has initiated its Phase 3 enlighten I trial of LYR-210 in adult...
January 24, 2022, 12:37 pm
Lyra therapeutics kickstarts lyr-210 pivotal program in surgically naïve chronic rhinosinusitis patients
Lyra Therapeutics Inc (NASDAQ: LYRA) has initiated its Phase 3 enlighten I trial of LYR-210 in adult...
January 24, 2022, 12:37 pm
Lyra therapeutics kickstarts lyr-210 pivotal program in surgically naïve chronic rhinosinusitis patients
Lyra Therapeutics Inc (NASDAQ: LYRA) has initiated its Phase 3 enlighten I trial of LYR-210 in adult...
January 24, 2022, 12:37 pm